Imagine a doctor who does not have to rely only on a tablet, an injection or a large surgical instrument.

Instead, imagine a microscopic machine entering a difficult-to-reach part of the body, being guided toward a precise location and delivering treatment there.

It sounds like science fiction.

But researchers around the world are working to make different versions of this idea real—and an Indian deep-tech startup is among the companies pushing the technology forward.

Bengaluru-based Theranautilus, founded in 2020, is developing nanorobotic systems for therapeutic applications. The company was recently named Top Innovator at the Economic Times Startup Awards 2026 for its work on microscopic robots designed to navigate inside the human body for targeted, minimally invasive treatments. The company has said human trials for its dental application are planned for September 2026.

But before we call this the future of medicine, there is an important distinction to make.

This technology is promising. It is not yet routine medical treatment.

And that distinction is where the real story begins.

---

The Problem With “One Medicine for Everyone”

Many medicines travel throughout the body after they are administered.

That is useful—but it is not always efficient.

A drug intended to act at one location may also circulate elsewhere. Conventional drug-delivery systems can face problems involving targeting, dosage control, biological barriers and unwanted effects.

This is one reason researchers are exploring microrobots and nanorobots that could potentially transport therapeutic materials closer to where they are needed.

A 2026 review in Current Drug Discovery Technologies describes microrobots as promising platforms for combining diagnosis and precision drug delivery, while also highlighting major challenges including scalability, biocompatibility and regulatory approval.

Another 2026 review of magnetically guided microrobots notes that these systems can potentially be externally guided and used for localized delivery, but stresses that clinical translation remains challenging.

So the fundamental idea is relatively simple:

Instead of sending treatment everywhere and hoping enough reaches the right place, can we make the treatment more precise?

---

Meet the Tiny Machines

The word “nanobot” creates an immediate mental image of a miniature robot swimming through a bloodstream like something from a movie.

Reality is more complicated.

The field includes a wide range of microscopic and nanoscale systems. Some can be moved using magnetic fields. Others use chemical, biological or physical mechanisms. Some carry therapeutic payloads; others are being investigated for sensing, imaging or localized intervention.

Researchers have been developing magnetic microrobots, including helical structures and biohybrid systems, with the potential to transport drugs, cells or diagnostic agents.

Theranautilus describes its work as nanorobotics for therapeutic applications. Its Bengaluru team is associated with the Indian Institute of Science ecosystem.

That makes the company’s work interesting not simply because the robots are tiny.

It is interesting because miniaturisation is being combined with controlled movement and medical purpose.

---

From a Tooth to a Much Bigger Idea

One of Theranautilus and IISc’s most visible developments has been in dentistry.

Researchers developed CalBots, magnetic nanobots designed to address dentin hypersensitivity.

According to reporting on the research, the particles are around 400 nanometres in size and were designed to travel deep into dentinal tubules. Under an externally applied magnetic field, they can form mineral-like plugs intended to restore the tooth’s barrier. The technology was tested on extracted human teeth and subsequently evaluated in animal experiments.

Why is this important?

Because tooth sensitivity is a very specific problem.

Rather than simply applying a material to the surface of the tooth, the concept attempts to take the treatment deeper into the microscopic structures responsible for the problem.

That is the larger promise of nanorobotics:

Go smaller. Go deeper. Target more precisely.

The dental application may therefore be viewed as more than a dental innovation. It is a demonstration of a broader technological philosophy.

---

But Can They Really “Swim” Through Your Body?

This is where headlines can become misleading.

A medical microrobot is not necessarily an autonomous little machine with its own computer, camera and artificial intelligence making decisions independently inside your body.

Different systems work in very different ways.

Some experimental microrobots can be manipulated through external magnetic fields. Others use chemical propulsion, biological mechanisms or combinations of technologies. Tracking and navigation may involve imaging systems such as ultrasound, MRI, X-ray or photoacoustic imaging.

Researchers are also investigating systems that can carry drugs or other therapeutic payloads and release them in response to specific stimuli.

So the more accurate picture is not:

“Tiny robots independently hunting diseases.”

It is:

“Microscopic engineered systems whose movement, function or payload can potentially be controlled or triggered in a medically useful way.”

That difference matters.

---

The Bigger Future: Medicine That Goes Where Doctors Cannot

The most exciting possibility is not necessarily replacing doctors.

It is extending what doctors can do.

Microrobotic systems are being researched for applications ranging from targeted drug delivery to diagnosis and minimally invasive procedures. A 2026 Nature Reviews Bioengineering article, for example, examined microrobots for pulmonary drug delivery, highlighting the potential advantage of localised treatment in diseased lung tissue while also pointing to the engineering challenges involved.

Recent research has also explored magnetic microrobots for gastrointestinal drug delivery, where the system has to deal with barriers such as mucus, changing pH and peristaltic motion.

The possible applications are therefore much broader than dentistry.

In the longer term, researchers are investigating possibilities involving:

• Targeted drug delivery
• Cancer treatment
• Difficult-to-reach tissues
• Gastrointestinal medicine
• Pulmonary medicine
• Diagnostics and sensing
• Image-guided treatment
• Minimally invasive procedures

But these possibilities should be described as areas of research and potential applications, not as treatments that are already available to patients.

---

The Questions We Should Be Asking

As an interviewer, the most interesting questions are not:

“Are nanobots going to change medicine?”

That question is too easy.

The better questions are:

1. How do you control something this small?

If the system is inside the body, how does the medical team know where it is and where it is going?

2. What happens when the mission is over?

Can the system be removed? Does it naturally break down? Does it remain in the body?

3. How safe is it?

A device intended to treat disease must itself avoid creating new problems.

4. Can the technology be manufactured at scale?

Making one impressive microscopic device in a laboratory is very different from manufacturing millions of consistent medical-grade systems.

5. How will regulators evaluate it?

Nanorobotics sits at the intersection of medicine, materials science, robotics and biotechnology. Regulatory pathways may be complex.

6. Will it actually improve patient outcomes?

This may ultimately be the most important question.

A technology can be fascinating and technically brilliant—but medicine ultimately demands evidence of safety, effectiveness and meaningful benefit.

---

The Reality Check

This is where the excitement around nanorobotics needs to meet scientific discipline.

A 2026 review of autonomous microrobots identifies several obstacles to clinical translation, including biosafety, systemic controllability and regulatory science.

Other research highlights challenges around movement speed, navigation through complex biological environments and the limitations of current systems.

In other words:

The technology may be moving fast. Medicine cannot afford to move recklessly.

Before microscopic robotic systems become routine clinical tools, researchers will need to establish reliable control, predictable behaviour, biocompatibility, manufacturing consistency, safety and clinical effectiveness.

That could take years.

---

Why India Matters in This Story

There is another reason this story deserves attention.

It is not simply about a futuristic technology being developed somewhere in Silicon Valley, Boston or Shenzhen.

An Indian research ecosystem is participating in the development of medical nanorobotics.

Theranautilus emerged from Bengaluru’s deep-tech and research environment, with links to the Indian Institute of Science ecosystem.

Its recent recognition at the ET Startup Awards 2026 places the company among Indian deep-tech ventures receiving significant attention for ambitious technology development.

That matters because India’s technology story is increasingly moving beyond software.

The next generation of Indian innovation may come from laboratories working across:

materials + medicine + robotics + biotechnology + engineering.

And that is exactly where the most interesting stories often begin.

---

What Happens Next?

Theranautilus’ reported plan to move toward human trials for its dental technology in September 2026 will be an important milestone—but a trial is not the same thing as a finished medical product.

If clinical development succeeds, the significance could extend beyond treating tooth sensitivity.

The larger question would become:

Can the same principles be adapted to other medical problems?

That is where the idea becomes truly ambitious.

A tiny system that can be precisely controlled in one relatively accessible environment could eventually inspire approaches for increasingly difficult biological environments.

But that future still has to be earned through evidence.

---

THE UNPLANNED VERDICT

PROMISING — BUT NOT YET PROVEN

The tiny-robot revolution has not arrived in hospitals.

Not yet.

But the science has moved beyond pure science fiction.

Researchers are demonstrating increasingly sophisticated approaches to microscopic navigation, targeted delivery and minimally invasive intervention. India is participating in that race, and Theranautilus is one of the companies making the story particularly interesting.

The real breakthrough may not be the creation of a “robot doctor” inside the human body.

It may be something more subtle:

A future in which medicine becomes precise enough to treat the problem without disturbing everything around it.

And if that future arrives, the biggest revolution in medicine may be measured not in metres or centimetres—

but in micrometres.

---

THE NEXT BIG THING

Tiny robots. Smaller than a grain of dust.
A very big question for the future of medicine.

THE UNPLANNED explores the ideas, people and technologies that could shape what comes next.